Apogee Therapeutics, Inc. APGE Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| $131.55M-7.2% | $141.79M+19.8% | $118.32M-22.1% | ||
| $598.64M+58.0% | $378.86M+36.7% | $277.14M— | ||
| $741.36M+40.0% | $529.71M+33.0% | $398.41M+162% | ||
| $5.69M+190% | $1.96M+420% | $377K— | ||
| $937.13M+24.3% | $753.95M+87.8% | $401.4M+164% | ||
| $9.72M-25.9% | $13.12M-12.4% | $14.98M— | ||
| $27.91M-2.3% | $28.56M+38.9% | $20.56M+106% | ||
| $33.25M-10.5% | $37.16M+72.9% | $21.49M+115% | ||
| $1K0.0% | $1K— | —— | ||
| -$561.76M-83.6% | -$305.92M-147% | -$123.77M-211% | ||
| $937.13M+24.3% | $753.95M+87.8% | $401.4M+164% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Apogee Therapeutics, Inc.'s total assets?
- Apogee Therapeutics, Inc. (APGE) holds $1.3B in total assets, up 81.1% year over year.
- How much cash does Apogee Therapeutics, Inc. have?
- Apogee Therapeutics, Inc. holds $451.8M in cash and equivalents.
- Can Apogee Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 32.59 — current assets exceed current liabilities.
- Where does Apogee Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Apogee Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.